Donor Pericardial Interleukin and Apolipoprotein Levels May Predict the Outcome after Human Orthotopic Heart Transplantation
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076780 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Éva Pállinger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Cell- and Immunobiology, Semmelweis University, 1085 Budapest, Hungary. Hauptthemen laut MEDLINE: Heart Transplantation, Primary Graft Dysfunction, Tissue and Organ Procurement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, Thematic Excellence Programme (2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary.
Abstract (Originalsprache)
The proinflammatory cascade that is activated at the time of brain death plays a crucial role in organ procurement. Our aim of this study was to explore the relationship between the clinical outcome of orthotopic heart transplantation, as well as cytokine and apolipoprotein profiles of the pericardial fluid obtained at donation. Interleukin, adipokine and lipoprotein levels in the pericardial fluid, as well as clinical data of twenty donors after brain death, were investigated. Outcome variables included primary graft dysfunction, the need for posttransplantation mechanical cardiac support and International Society for Heart and Lung Transplantation grade ≥ 2R rejection. Hormone management and donor risk scores were also investigated. Lower levels of IL-6 were observed in primary graft dysfunction (median: 36.72 [IQR: 19.47–62.90] versus 183.67 [41.21–452.56]; p = 0.029) and in the need for mechanical cardiac support (44.12 [20.12–85.70] versus 247.13 [38.51–510.38]; p = 0.043). Rejection was associated with lower ApoAII (p = 0.021), ApoB100 (p = 0.032) and ApoM levels (p = 0.025). Lower adipsin levels were detected in those patients receiving desmopressin (p = 0.037); moreover, lower leptin levels were found in those patients receiving glucocorticoid therapy (p = 0.045), and higher T3 levels were found in those patients treated with L-thyroxine (p = 0.047) compared to those patients not receiving these hormone replacement therapies. IL-5 levels were significantly associated with UNOS-D score (p = 0.004), Heart Donor Score (HDS) and Adapted HDS (p < 0.001). The monitoring of immunological and metabolic changes in donors after brain death may help in the prediction of potential complications after heart transplantation, thus potentially optimizing donor heart allocation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Cell- and Immunobiology, Semmelweis University, 1085 Budapest, Hungary.
- Department of Anesthesiology and Intensive Therapy, Semmelweis University, 1085 Budapest, Hungary.
- Heart and Vascular Center, Semmelweis University, 1085 Budapest, Hungary.
- Faculty of Medicine, Semmelweis University, 1085 Budapest, Hungary.
- Doctoral School of Theoretical and Translational Medicine, Semmelweis University, 1085 Budapest, Hungary.
- HCEMM-SU Extracellular Vesicle Research Group, Semmelweis University, 1085 Budapest, Hungary.
ORCID-Profile: Andrea Székely, Evelin Töreki, Balázs Szécsi, Annamária Kosztin, Edit I Buzas
Förderung
- European Union
- Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund
- Thematic Excellence Programme (2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary
- National Research, Development and Innovation Office (NKFIH) of Hungary
- European Union's Horizon 2020 Research and Innovation Programme
- National Research, Development and Innovation Fund of Hungary
- European Union’s Horizon 2020 Research and Innovation Programme
Zitieren
APA
Pállinger, É., Székely, A., Töreki, E., Bencsáth, E. Z., Szécsi, B., Losoncz, E., Oleszka, M., Hüttl, T., Kosztin, A., Buzas, E. I., Radovits, T., & Merkely, B. (2023). Donor Pericardial Interleukin and Apolipoprotein Levels May Predict the Outcome after Human Orthotopic Heart Transplantation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076780
Vancouver
Pállinger É, Székely A, Töreki E, Bencsáth EZ, Szécsi B, Losoncz E, et al. Donor Pericardial Interleukin and Apolipoprotein Levels May Predict the Outcome after Human Orthotopic Heart Transplantation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076780
BibTeX
@article{Pllinger2023,
author = {Pállinger, Éva and Székely, Andrea and Töreki, Evelin and Bencsáth, Erzsébet Zsófia and Szécsi, Balázs and Losoncz, Eszter and Oleszka, Máté and Hüttl, Tivadar and Kosztin, Annamária and Buzas, Edit I and Radovits, Tamás and Merkely, Béla},
title = {Donor Pericardial Interleukin and Apolipoprotein Levels May Predict the Outcome after Human Orthotopic Heart Transplantation},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076780}
}
EUVIMED